dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with ciglitazone in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (ciglitazone) | Trials (ciglitazone) | Recent Studies (post-2010) (ciglitazone) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 473 | 0 | 77 |
| Protein | Taxonomy | dibutyryl cyclic-3',5'-cytidine monophosphate (IC50) | ciglitazone (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 4.655 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.086 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.22 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.047 | |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Homo sapiens (human) | 2.7 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.22 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.225 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dyson, MT; Kowalewski, MP; Manna, PR; Stocco, DM | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and ciglitazone
| Article | Year |
|---|---|
Involvement of peroxisome proliferator-activated receptor gamma in gonadal steroidogenesis and steroidogenic acute regulatory protein expression.
Topics: Animals; Binding Sites; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyclic AMP Response Element Modulator; Cyclic AMP Response Element-Binding Protein; Cyclic CMP; Dose-Response Relationship, Drug; Female; GATA4 Transcription Factor; Granulosa Cells; Leydig Cells; Male; Mice; Mitogen-Activated Protein Kinases; Phosphoproteins; PPAR gamma; Progesterone; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; RNA, Messenger; Signal Transduction; Steroidogenic Factor 1; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones; Transfection | 2009 |